Exhibit 31.2

     I, Xinhua Wu, the Chief Financial  Officer of China Pharma Holdings,  Inc.,
certify that:

     1) I have  reviewed  this  quarterly  report on Form 10-QSB of China Pharma
Holdings, Inc.;

     2) Based on my knowledge, this report does not contain any untrue statement
of a  material  fact or omit to  state a  material  fact  necessary  to make the
statements made, in light of the circumstances  under which such statements were
made, not misleading with respect to the period covered by this report;

     3) Based on my knowledge,  the financial  statements,  and other  financial
information included in this report, fairly present in all material respects the
financial condition,  results of operations and cash flows of the small business
issuer as of, and for, the periods presented in this report;

     4) The  small  business  issuer's  other  certifying  officer(s)  and I are
responsible for establishing and maintaining  disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal  control
over  financial  reporting  (as  defined in  Exchange  Act Rules  13a-15(f)  and
15d-15(f)) for the small business issuer and have:

               a) Designed such disclosure  controls and  procedures,  or caused
such disclosure controls and procedures to be designed under our supervision, to
ensure  that  material  information  relating  to  the  small  business  issuer,
including its  consolidated  subsidiaries,  is made known to us by others within
those  entities,  particularly  during the period in which this  report is being
prepared;

               b) Designed such internal  control over financial  reporting,  or
caused such internal  control over financial  reporting to be designed under our
supervision,  to provide  reasonable  assurance  regarding  the  reliability  of
financial  reporting and the  preparation  of financial  statements for external
purposes in accordance with generally accepted accounting principles;

               c) Evaluated the  effectiveness  of the small  business  issuer's
disclosure  controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and

               d)  Disclosed  in this  report any  change in the small  business
issuer's  internal  control over financial  reporting  that occurred  during the
small business issuer's most recent fiscal quarter that has materially affected,
or is  reasonably  likely to  materially  affect,  the small  business  issuer's
internal control over financial reporting; and

     5) The small  business  issuer's  other  certifying  officer(s)  and I have
disclosed,  based  on our  most  recent  evaluation  of  internal  control  over
financial  reporting,  to the small  business  issuer's  auditors  and the audit
committee  of the  small  business  issuer's  board  of  directors  (or  persons
performing the equivalent functions):

               a) All significant  deficiencies  and material  weaknesses in the
design or  operation  of internal  control over  financial  reporting  which are
reasonably  likely to adversely  affect the small business  issuer's  ability to
record, process, summarize and report financial information; and

               b) Any fraud,  whether or not material,  that involves management
or other  employees who have a significant  role in the small business  issuer's
internal control over financial reporting.



                                                   Date: November 13, 2007

                                                   By:   /s/ Xinhua Wu
                                                         -------------
                                                             Xinhua Wu
                                                       Chief Financial Officer